Celyad Oncology SA
XBRU:CYAD

Watchlist Manager
Celyad Oncology SA Logo
Celyad Oncology SA
XBRU:CYAD
Watchlist
Price: 0.5 EUR -11.19% Market Closed
Market Cap: 20.7m EUR
Have any thoughts about
Celyad Oncology SA?
Write Note

Celyad Oncology SA
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Celyad Oncology SA
Operating Income Peer Comparison

Comparables:
M
MDXH
GLPG
OXUR

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Celyad Oncology SA
XBRU:CYAD
Operating Income
-€7.8m
CAGR 3-Years
20%
CAGR 5-Years
26%
CAGR 10-Years
N/A
M
MDxHealth SA
NASDAQ:MDXH
Operating Income
-$36.1m
CAGR 3-Years
-11%
CAGR 5-Years
-3%
CAGR 10-Years
-4%
Galapagos NV
AEX:GLPG
Operating Income
-€189.8m
CAGR 3-Years
-9%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Oxurion NV
XBRU:OXUR
Operating Income
-€12m
CAGR 3-Years
25%
CAGR 5-Years
21%
CAGR 10-Years
N/A

See Also

What is Celyad Oncology SA's Operating Income?
Operating Income
-7.8m EUR

Based on the financial report for Jun 30, 2024, Celyad Oncology SA's Operating Income amounts to -7.8m EUR.

What is Celyad Oncology SA's Operating Income growth rate?
Operating Income CAGR 5Y
26%

Over the last year, the Operating Income growth was 74%. The average annual Operating Income growth rates for Celyad Oncology SA have been 20% over the past three years , 26% over the past five years .

Back to Top